Bullish Analyst Perspective: Vertex Pharma (VRTX), Knowles (KN), Boston Scientific (BSX), Team Health Holdings (TMH)
Investment analysts at Argus upgraded shares of Vertex Pharmaceuticals Inc. (VRTX) from Hold to Buy with a price target of $126.00
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives.
Brokerage firm FBR Capital upgraded shares of Knowles Corp. (KN) from an Underperform to a Market Perform rating and raised its price target on the company's stock from $17.00 to $18.00
Knowles is a market leader and global supplier of advanced micro-acoustic solutions and specialty components serving the mobile communications, consumer electronics, medical technology, military, aerospace and industrial markets.
Boston Scientific Corp. (BSX) was upgraded by stock analysts at Needham from Hold to Buy with a price target of $21.00 per share
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
Research analysts at Stifel raised their price target on shares of Team Health Holdings, Inc. (TMH) from $68.00 to $71.00, while maintaining a Buy rating
Team Health Holdings is a leading provider of physician and other clinical services for hospitals in the United States.
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE PR Finance www.finance.crwe-pr.com/disclaimer